Nephros, Inc. (NEPH)
4.48
+0.10
(+2.28%)
USD |
NASDAQ |
Jan 16, 16:00
4.47
-0.01
(-0.22%)
Pre-Market: 20:00
Nephros EPS Diluted (Quarterly): 0.0305 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Apyx Medical Corp. | -0.0487 |
| Owlet, Inc. | 0.1338 |
| Perspective Therapeutics, Inc. | -0.3495 |
| InfuSystem Holdings, Inc. | 0.1078 |
| Xtant Medical Holdings, Inc. | 0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.337M |
| Revenue (Quarterly) | 4.764M |
| Total Expenses (Quarterly) | 4.427M |
| Enterprise Value | 43.59M |
| Gross Profit Margin (Quarterly) | 60.47% |
| Profit Margin (Quarterly) | 7.07% |
| Earnings Yield | 3.08% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | 3.083 |